Phosphoric Acid Monotetradecyl Ester

Phosphoric Acid Monotetradecyl Ester

SCHEMBL1712593

CCCCCCCCCCCCCCOP(=O)([O-])[O-].[Na+].[Na+]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phosphoric Acid Monotetradecyl Ester. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 known ✓ P0DMS8 1/20 0.58
LPAR3 Q9UBY5 8/20 0.61
LPAR2 Q9HBW0 6/20 0.61
LPAR1 Q92633 3/20 0.61
AKT1 P31749 2/20 0.58
CDC25A P30304 2/20 0.58
LMNA P02545 1/20 0.58
ESR1 P03372 1/20 0.58
AGTR1 P30556 1/20 0.58
ADRA1A P35348 1/20 0.58
KCNH2 Q12809 1/20 0.58
CYP3A4 P08684 1/20 0.52
RECQL P46063 2/20 0.48
GLA P06280 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
EPHX2 P34913 1/20 0.48
BLM P54132 1/20 0.48
TERT O14746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28883666 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL9051802 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A
Phosphoric Acid Monododecyl Ester SCHEMBL271509 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL10858725 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL9051772 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL1951141 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL5441454 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL9805681 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A
Hexadecyl Dihydrogen Phosphate SCHEMBL258112 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL28359287 1.00 LPAR3 (0.61) LPAR3LPAR2LPAR1AKT1CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119591634-A Method for regulating and controlling solubility of disodium mono-tetradecyl phosphate by pH 江南大学 2025-03-11 CN claimed
CN-119524666-A Preparation method of high-stability high internal phase emulsion emulsified by disodium mono-tetradecyl phosphate 江南大学 2025-02-28 CN claimed
CN-114655996-B Oxygen evolution electrocatalyst of chiral cobaltosic oxide and preparation method thereof 上海电力大学 2024-02-27 CN claimed
CN-114655996-A Oxygen evolution electrocatalyst of chiral cobaltosic oxide and preparation method thereof 上海电力大学 2022-06-24 CN claimed
CN-122060245-A Antistatic resin composition 东邦化学工业株式会社 2026-05-19 CN disclosed
US-20260090962-A1 SURFACE TREATED HYDROPHOBIC CELLULOSE MIYOSHI AMERICA INC (US) 2026-04-02 US disclosed
EP-4717252-A1 SURFACE TREATED HYDROPHOBIC CELLULOSE Miyoshi America Inc. (US) 2026-04-01 EP disclosed
EP-4066903-B1 SKIN CLEANSING AGENT KAO CORP (JP) 2025-11-05 EP disclosed
CN-119524666-B Preparation method of high-stability high internal phase emulsion emulsified by disodium mono-tetradecyl phosphate 江南大学 2025-10-10 CN disclosed
WO-2025126659-A1 FOAMING AGENT COMPOSITION 花王株式会社 2025-06-19 WO disclosed
CN-119591634-A Method for regulating and controlling solubility of disodium mono-tetradecyl phosphate by pH 江南大学 2025-03-11 CN disclosed
CN-119591634-A Method for regulating and controlling solubility of disodium mono-tetradecyl phosphate by pH 江南大学 2025-03-11 CN disclosed
EP-1669055-A1 DETERGENT COMPOSITION Asahi Kasei Chemicals Corporation (JP) 2006-06-14 EP disclosed
US-20040156802-A1 Cosmetics or external preparations for skin AJINOMOTO CO., INC. (JP) 2004-08-12 US disclosed
EP-1374831-A1 COMSETICS OR EXTERNAL PREPARAIOTNS FOR SKIN Ajinomoto Co., Inc. (JP) 2004-01-02 EP disclosed
EP-0767191-B1 Polymer, preparation process thereof, hairtreating compositions and cosmetic compositions MITSUI CHEMICALS INC (JP) 2003-03-12 EP disclosed
US-5686066-A Polyaspartic acid Zwitterionic derivatives, preparation processes thereof, hair-treating compositions and cosmetic compositions MITSUI TOATSU CHEMICALS, INC. (JP) 1997-11-11 US disclosed
EP-0767191-A2 Polymer, preparation process thereof, hairtreating compositions and cosmetic compositions MITSUI TOATSU CHEMICALS, INC. (JP) 1997-04-09 EP disclosed
US-5374418-A An antibacterial compound comprising a nitrogen-containing cation with a monoalkyl phosphate anion; rapid and continued disinfection with good taste KAO CORPORATION (JP) 1994-12-20 US disclosed
US-4505935-A Protective layer on skin, mucous membrane or other body tissue LARSSON VIKTOR K (SE) 1985-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040156802-A1 Cosmetics or external preparations for skin CUTA, PSAP, CTH ADORA3 2611/4885LPAR3 1024/4885LPAR2 1133/4885
US-20260090962-A1 SURFACE TREATED HYDROPHOBIC CELLULOSE CUTA, SMURF1, SMURF2 ADORA3 2495/4885LPAR3 2774/4885LPAR2 3378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.